| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2023―Mar―11 |
An integrated approach of high-performance liquid chromatography-mass spectrometry-based chemical profiling, network pharmacology, and molecular docking to reveal the potential mechanisms of Qishen Gubiao granules for treating coronavirus disease 2019 |
Shu-Yun Yang, Ming-Xia Lu, Yun-Qian Zhang, Jian-Cheng Liao, Jian-Dong Zou, Wen-Lei Li, et al. (+3) Wei Shi, Zhu-Yuan Fang, Chang-Yin Li |
| 2 |
[GO] |
2022―Sep―28 |
Protein-imprinted particles for coronavirus capture from solution |
Naomi L. Senehi, Matthew R. Ykema, Ruonan Sun, Rafael Verduzco, Lauren B. Stadler, Yizhi J. Tao, Pedro J.J. Alvarez |
| 3 |
[GO] |
2022―Aug―11 |
Sensitive and Selective Bioscreening of the Most Commonly Used Coronavirus Disease Drug, Favipiravir, and Its Co-Administered therapeutic, Meropenem, in Human Plasma |
Rehab M. Abdelfatah, Eglal A. Abdelaleem, Esraa H. Abdelmomen, Refaat H. Abdelmoety, Aml A. Emam |
| 4 |
[GO] |
2021―Nov―19 |
Front Cover: Phytometabolite profiling of Coronil, a herbal medicine for COVID-19, its identification by mass-spectroscopy and quality validation on liquid chromatographic platforms |
Acharya Balkrishna, Meenu Tomer, Sudeep Verma, Monali Joshi, Priyanka Sharma, Jyotish Srivastava, Anurag Varshney |
| 5 |
[GO] |
2021―Sep―12 |
Phyto-metabolite profiling of Coronil, a herbal medicine for COVID-19, its identification by mass-spectroscopy and quality validation on liquid chromatographic platforms |
Acharya Balkrishna, Meenu Tomer, Sudeep Verma, Monali Joshi, Priyanka Sharma, Jyotish Srivastava, Anurag Varshney |
|
